The content is available as a PDF (569.6 KB).
. 2023 May 10;25(6):S152–S153. doi: 10.1016/S1465-3249(23)00417-6
Embryonic, Organ and Other Tissue Specific Stem Cells: BONE MARROW MESENCHYMAL STEM CELL DERIVED EXTRACELLULAR VESICLE INFUSION FOR SEVERE OR CRTIICAL COVID-19 RESPIRATORY FAILURE: A RANDOMIZED CLINICAL TRIAL
A Lightner
, E Schmidt
, S Sengupta
, V Sengupta
, D Park
, T Melson
, B Williams
, J Walsh
, M Awili
A Lightner
Find articles by A Lightner
E Schmidt
Find articles by E Schmidt
S Sengupta
Find articles by S Sengupta
V Sengupta
Find articles by V Sengupta
D Park
Find articles by D Park
T Melson
Find articles by T Melson
B Williams
Find articles by B Williams
J Walsh
Find articles by J Walsh
M Awili
Find articles by M Awili
Issue date 2023 May.
Copyright © 2023 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC10171024